You are here

obesity

Highlights: 2019 Cardiometabolic Health Congress, Chicago IL

CP Wire

Tue, 10/29/19 - 01:55 pm

cardiometabolic health

chronic kidney disease

Highlights: 2019 Cardiometabolic Health Congress, Chicago IL

Tue, 10/29/19 - 01:54 pm

cardiometabolic health

chronic kidney disease

Novo Nordisk announces obesity digital health tie-up with Noom

Pharmaforum

Thu, 10/3/19 - 10:53 am

J&J dumps Hanmi obesity drug following midphase trials

Fierce Biotech

Mon, 07/8/19 - 10:51 am

Hanmi Pharmaceutical

Boehringer Ingelheim, Gubra to develop anti-obesity peptide poly-agonists

Pharmaceutical Business Review

Thu, 05/30/19 - 10:05 am

peptide poly-agonists

Boehringer Ingelheim

Even as obesity rates climb, new diabetes cases fall

Stat

Tue, 05/28/19 - 11:54 am

FDA approves PureTech’s obesity device Plenity

Pharmaforum

Mon, 04/15/19 - 10:27 am

PureTech Health

Obalon to lay off half its workforce in retail pivot

Mass Device

Wed, 04/3/19 - 12:16 pm

Merck doubles down on NGM Bio pact but culls obesity drug

Fierce Biotech

Wed, 03/20/19 - 12:15 pm

NGM Biopharmaceuticals

With Obesity on the Continued Rise in the U.S., More Anti-Obesity Drugs Are Heading for the Market

BioSpace

Wed, 02/13/19 - 10:06 am

Obalon Scores Funding on the Heels of Obesity Market Shift

Medical Devices and Diagnostics Industry

Fri, 12/28/18 - 01:05 pm

LNC Therapeutics Acquires Exclusive License for Microbes Potentially Related to Obesity

CP Wire

Thu, 10/18/18 - 12:35 am

LNC Therapeutics

Belviq Study Results May Improve The Fortunes Of Weight-Loss Drugs

Forbes

Mon, 09/10/18 - 11:41 am

Novo Nordisk adds to diabetes pipeline with Evotec deal

Fierce Biotech

Thu, 08/23/18 - 10:13 am

drug development

small molecule drugs

Eisai obesity drug Belviq may have an edge with new heart safety data—but to what end?

Fierce Pharma

Wed, 07/18/18 - 10:56 am

Omada Health launches new programs for obesity-related diseases

Healthcare Dive

Fri, 06/22/18 - 07:52 pm

digital therapeutics

Novo Nordisk in Deal with Kallyope for Obesity, Diabetes Drugs

Yahoo/Zacks.com

Wed, 06/20/18 - 10:20 pm

Building up its rare obesity pipeline, Rhythm Pharma to raise $150M

Endpoints

Tue, 06/19/18 - 10:53 am

Rhythm Pharmaceuticals

Gut Microbes Associated With Obesity May Contribute to Depression and Anxiety

CP Wire

Mon, 06/18/18 - 11:15 am

Novo Nordisk's semaglutide spurs major weight loss in phase 2 obesity study

Fierce Pharma

Mon, 03/19/18 - 11:40 pm

Pages